Reference
Inci M, et al. Recurrent intracerebral hemorrhage due to alemtuzumab treatment in a patient with multiple sclerosis: Case report. Neurology 94 (Suppl.): no pagination, No. 15, Jan 2020. Available from: URL: https://cslide-us.ctimeetingtech.com/aan2020/attendee/eposter/poster/3109 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab/natalizumab. Reactions Weekly 1828, 29 (2020). https://doi.org/10.1007/s40278-020-85105-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85105-4